We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
How Acadia Healthcare Is Turning Capacity Growth Into Cash Flow
Read MoreHide Full Article
Key Takeaways
Acadia Healthcare added 240 beds in Q2 and remains on track to add 500-600 beds this year.
Acute inpatient volumes rose 5.5%, while newer facilities could add $200 million in adjusted EBITDA.
Acadia Healthcare generated $124 million in Q2 free cash flow and used $113 million to reduce debt.
Acadia Healthcare Company, Inc. (ACHC - Free Report) has entered the second half of 2026 with improving cash generation as newer facilities begin contributing more meaningfully to operations. The shift is important because the company has invested in expanding its network, and stronger facility performance should allow it to capture greater value from that capacity.
The expanded capacity is beginning to support higher patient volumes. During the second quarter, Acadia opened two joint-venture facilities adding 240 licensed beds, keeping it on track to add 500 to 600 beds this year. At the same time, acute inpatient volumes grew 5.5% year over year, reflecting stronger utilization across its acute facilities. The company also expects newer facilities to contribute about $200 million in incremental adjusted EBITDA compared with 2025 levels as they mature.
Acadia is becoming more disciplined with capital deployment. Its 2026 capital expenditure outlook was lowered to $235-$255 million, reflecting project timing and a greater focus on free cash flow. Combined with improving working-capital trends, this helped the company generate $124 million in free cash flow during the second quarter.
The stronger cash profile is giving Acadia room to address its balance sheet while continuing to invest in growth. The company used $113 million to reduce debt during the quarter and expects positive free cash flow in the second half. If facility performance remains on track and capital spending stays disciplined, capacity expansion could increasingly boost cash generation rather than consume significant amounts of cash.
How Are Competitors Faring?
Peers such as Universal Health Services, Inc. (UHS - Free Report) and The Ensign Group, Inc. (ENSG - Free Report) are also pursuing growth while improving facility utilization and financial efficiency.
Universal Health shows how stronger utilization can translate into better profitability. UHS’ behavioral-health business posted 7.4% revenue growth in the second quarter, while same-facility EBITDA increased, suggesting that higher demand is helping facilities generate greater earnings from existing capacity.
The Ensign Group offers a similar example of utilization supporting cash generation. ENSG’s same-facility occupancy rose to 84.1%, while operating cash flow reached $272.1 million in the first half. The strong cash flow provides greater flexibility to reinvest in facility growth.
ACHC’s Price Performance, Valuation & Estimates
Shares of Acadia have gained 28.8% over the past year compared with the industry’s 14.2% growth over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, ACHC trades at a forward price-to-earnings ratio of 16.55X, up from the industry average of 11X. ACHC carries a Value Score of C.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for ACHC’s 2026 earnings is pegged at $1.55 per share, followed by 14.4% growth next year.
View the Zacks #1 Rank List
Image: Bigstock
How Acadia Healthcare Is Turning Capacity Growth Into Cash Flow
Key Takeaways
Acadia Healthcare Company, Inc. (ACHC - Free Report) has entered the second half of 2026 with improving cash generation as newer facilities begin contributing more meaningfully to operations. The shift is important because the company has invested in expanding its network, and stronger facility performance should allow it to capture greater value from that capacity.
The expanded capacity is beginning to support higher patient volumes. During the second quarter, Acadia opened two joint-venture facilities adding 240 licensed beds, keeping it on track to add 500 to 600 beds this year. At the same time, acute inpatient volumes grew 5.5% year over year, reflecting stronger utilization across its acute facilities. The company also expects newer facilities to contribute about $200 million in incremental adjusted EBITDA compared with 2025 levels as they mature.
Acadia is becoming more disciplined with capital deployment. Its 2026 capital expenditure outlook was lowered to $235-$255 million, reflecting project timing and a greater focus on free cash flow. Combined with improving working-capital trends, this helped the company generate $124 million in free cash flow during the second quarter.
The stronger cash profile is giving Acadia room to address its balance sheet while continuing to invest in growth. The company used $113 million to reduce debt during the quarter and expects positive free cash flow in the second half. If facility performance remains on track and capital spending stays disciplined, capacity expansion could increasingly boost cash generation rather than consume significant amounts of cash.
How Are Competitors Faring?
Peers such as Universal Health Services, Inc. (UHS - Free Report) and The Ensign Group, Inc. (ENSG - Free Report) are also pursuing growth while improving facility utilization and financial efficiency.
Universal Health shows how stronger utilization can translate into better profitability. UHS’ behavioral-health business posted 7.4% revenue growth in the second quarter, while same-facility EBITDA increased, suggesting that higher demand is helping facilities generate greater earnings from existing capacity.
The Ensign Group offers a similar example of utilization supporting cash generation. ENSG’s same-facility occupancy rose to 84.1%, while operating cash flow reached $272.1 million in the first half. The strong cash flow provides greater flexibility to reinvest in facility growth.
ACHC’s Price Performance, Valuation & Estimates
Shares of Acadia have gained 28.8% over the past year compared with the industry’s 14.2% growth over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, ACHC trades at a forward price-to-earnings ratio of 16.55X, up from the industry average of 11X. ACHC carries a Value Score of C.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for ACHC’s 2026 earnings is pegged at $1.55 per share, followed by 14.4% growth next year.
Image Source: Zacks Investment Research
Acadia currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.